Intuitive Surgical Beats Q2 Earnings and Revenue Estimates

Intuitive Surgical (ISRG) reported second-quarter 2026 results on July 16, 2026 that beat on both lines, with non-GAAP EPS of $2.80 topping consensus by roughly $0.30 and revenue of $2.89 billion, up 19% year over year and ahead of the approximately $2.81 billion Street estimate .

Despite the beat, the stock declined about 8.53% in extended trading. On the call, Chief Executive Officer Dave Rosa pointed to continued global adoption of the da Vinci, da Vinci SP and Ion platforms even as U.S. procedure growth moderated and the China market stayed challenging . Worldwide procedures grew roughly 16% year over year, with da Vinci procedures up about 15% and Ion procedures up about 36%.

The company maintained its 2026 da Vinci procedure growth outlook of 13.5% to 15.5% and guided to a gross margin range of 68% to 69% . The muted reaction suggests investors had priced in a strong print and are focused on the pace of U.S. volume growth from here.

Related Stocks

• ISRG
• NDAQ